drugset / Trial / NCT01180894

IV Iron for the Anemia of Traumatic Critical Illness

NCT01180894

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical trial is to determine whether intravenous iron supplementation of anemic, critically ill trauma patients improves anemia and reduces the need for a red blood cell transfusion.

Timeline

Start
2011-06
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron sucrose Unknown 100 mg Intravenous

Indications